Your browser doesn't support javascript.
loading
Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.
Taft, Justin; Markson, Michael; Legarda, Diana; Patel, Roosheel; Chan, Mark; Malle, Louise; Richardson, Ashley; Gruber, Conor; Martín-Fernández, Marta; Mancini, Grazia M S; van Laar, Jan A M; van Pelt, Philomine; Buta, Sofija; Wokke, Beatrijs H A; Sabli, Ira K D; Sancho-Shimizu, Vanessa; Chavan, Pallavi Pimpale; Schnappauf, Oskar; Khubchandani, Raju; Cüceoglu, Müserref Kasap; Özen, Seza; Kastner, Daniel L; Ting, Adrian T; Aksentijevich, Ivona; Hollink, Iris H I M; Bogunovic, Dusan.
Afiliação
  • Taft J; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Markson M; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Legarda D; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Patel R; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Chan M; Department of Immunology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Malle L; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Richardson A; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Gruber C; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Martín-Fernández M; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Mancini GMS; Department of Clinical Genetics, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
  • van Laar JAM; Department of Immunology, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
  • van Pelt P; Department of Rheumatology, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
  • Buta S; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
  • Wokke BHA; Department of Neurology, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
  • Sabli IKD; Department of Paediatric Infectious Diseases and Virology, Imperial College London, London, UK; Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London, London, UK.
  • Sancho-Shimizu V; Department of Paediatric Infectious Diseases and Virology, Imperial College London, London, UK; Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London, London, UK.
  • Chavan PP; Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA; Pediatric Rheumatology, SRCC Children's Hospital, Mumbai, India.
  • Schnappauf O; Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA.
  • Khubchandani R; Pediatric Rheumatology, SRCC Children's Hospital, Mumbai, India; Consultant Pediatrician, Jaslok and Breach Candy Hospitals, Mumbai, India.
  • Cüceoglu MK; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey.
  • Özen S; Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey.
  • Kastner DL; Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA.
  • Ting AT; Department of Immunology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Aksentijevich I; Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA.
  • Hollink IHIM; Department of Clinical Genetics, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
  • Bogunovic D; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New Yor
Cell ; 184(17): 4447-4463.e20, 2021 08 19.
Article em En | MEDLINE | ID: mdl-34363755
TANK binding kinase 1 (TBK1) regulates IFN-I, NF-κB, and TNF-induced RIPK1-dependent cell death (RCD). In mice, biallelic loss of TBK1 is embryonically lethal. We discovered four humans, ages 32, 26, 7, and 8 from three unrelated consanguineous families with homozygous loss-of-function mutations in TBK1. All four patients suffer from chronic and systemic autoinflammation, but not severe viral infections. We demonstrate that TBK1 loss results in hypomorphic but sufficient IFN-I induction via RIG-I/MDA5, while the system retains near intact IL-6 induction through NF-κB. Autoinflammation is driven by TNF-induced RCD as patient-derived fibroblasts experienced higher rates of necroptosis in vitro, and CC3 was elevated in peripheral blood ex vivo. Treatment with anti-TNF dampened the baseline circulating inflammatory profile and ameliorated the clinical condition in vivo. These findings highlight the plasticity of the IFN-I response and underscore a cardinal role for TBK1 in the regulation of RCD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Proteínas Serina-Treonina Quinases / Inflamação Limite: Female / Humans / Male Idioma: En Revista: Cell Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Proteínas Serina-Treonina Quinases / Inflamação Limite: Female / Humans / Male Idioma: En Revista: Cell Ano de publicação: 2021 Tipo de documento: Article